(Q33753890)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21102547%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21102547%20AND%20SRC:MED&resulttype=core&format=json

ubiquitin-proteasome system

16 January 2020

main subject

0 references

author

Holger Sültmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21102547%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

O J C Hellwinkel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21102547%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

L E Asong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21102547%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

J-P Rogmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21102547%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

C Wagner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21102547%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

T Schlomm

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21102547%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

C Eichelberg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21102547%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

23 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21102547%20AND%20SRC:MED&resulttype=core&format=json

Prostate Cancer and Prostatic Diseases

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21102547%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21102547%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21102547%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

38-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21102547%20AND%20SRC:MED&resulttype=core&format=json

The ubiquitin-proteasome pathway and its role in cancer

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

A comprehensive analysis of transcript signatures of the phosphatidylinositol-3 kinase/protein kinase B signal-transduction pathway in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Ubiquitin: structures, functions, mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Bortezomib for the treatment of mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

A phase I trial of bortezomib with temozolomide in patients with advanced melanoma: toxicities, antitumor effects, and modulation of therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-line treatment of patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Transforming growth factor-beta1 and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Androgens differentially regulate the expression of NEDD4L transcripts in LNCaP human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Evidence for field cancerization of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

The Nedd4-like family of E3 ubiquitin ligases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent migration of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Pin1 down-regulates transforming growth factor-beta (TGF-beta) signaling by inducing degradation of Smad proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Smad ubiquitination regulatory factor 2 promotes metastasis of breast cancer cells by enhancing migration and invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

The ubiquitin-proteasome system and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Phase I/II study of bortezomib plus docetaxel in patients with advanced androgen-independent prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Transforming growth factor-beta in benign and malignant prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Nedd4L expression is downregulated in prostate cancer compared to benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

Altered levels of Smad2 and Smad4 are associated with human prostate carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.48

31 March 2020

Identifiers

DOI

10.1038/PCAN.2010.48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21102547%20AND%20SRC:MED&resulttype=core&format=json

release_65j3axod4nhrhjdpoqmj77d7eu

16 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/65j3axod4nhrhjdpoqmj77d7eu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference